A Tough Ending, New Beginnings and China-U.S. Biopharma Relations

Well-financed startup Tome is winding down operations just as two new companies, Borealis Biosciences and GondolaBio, are launching. Meanwhile, in the midst of already tense relations with China, House lawmakers raise the alarm about U.S. companies working with the the country’s military on trials.

Scroll to Top